KVYO:NYSEKlaviyo, Inc. Series A Analysis
Data as of 2026-05-24 - not real-time
$14.87
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Klaviyo’s shares are trading at $14.87, well below the 20‑day ($17.06), 50‑day ($18.08) and 200‑day ($24.91) moving averages, with an RSI of 38 and a bearish MACD histogram, indicating short‑term momentum pressure and a 30‑day volatility of over 130%. Yet the discounted cash‑flow model values the stock at $31.60, implying roughly a 96% upside, and the forward P/E of 14.4 is dramatically cheaper than the software‑application industry average of 39.5. Revenue surged 28% YoY to $1.31 B with a robust 74.5% gross margin, while operating cash flow of $238 M and a cash pile of $984 M give the company a strong liquidity cushion despite a modest GAAP operating margin of 0.5% and a current loss per share. Analysts are overwhelmingly bullish, with a “strong buy” consensus and a median price target of $30, reflecting confidence in the growth narrative. Recent earnings further reinforce this optimism: Q1 FY2026 revenue hit $358 M (+28% YoY) and non‑GAAP operating margin reached a record 16%, while EPS of $0.22 beat estimates by 13.4%. The stock now sits just above a support level of $13.53 and below a resistance of $23.52, with volume trending down but still near its 10‑day average, suggesting a potential rebound if sentiment improves. Morgan Stanley’s resumption of coverage adds credibility to the upside thesis, and the company’s low beta (0.86) tempers systematic market risk. Overall, the blend of strong cash generation, accelerating top‑line growth, and a valuation gap creates a compelling case for investors willing to navigate short‑term technical weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical indicators show bearish momentum and price near support
- Recent earnings beat and margin improvement could spark buying interest
- High short‑term volatility may cause price swings
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of ~28% YoY and expanding non‑GAAP operating margins
- DCF fair value indicating ~96% upside and attractive forward P/E
- Strong analyst consensus with median target around $30
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust cash position and positive free cash flow support sustainable growth
- Competitive moat in B2C SaaS and AI‑driven marketing platform
- Undervaluation relative to industry peers and long‑term upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth27.90%
Profit Margin-0.66%
P/E Ratio14.4
ROE-0.78%
ROA-1.66%
Debt/Equity10.16
P/B Ratio3.9
Op. Cash Flow$237.9M
Free Cash Flow$241.5M
Industry P/E39.5
Technical Analysis
TrendBearish
RSI38.0
Support$13.53
Resistance$23.52
MA 20$17.06
MA 50$18.08
MA 200$24.91
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$31.60
Target Price$29.23
Upside/Downside96.55%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.86
Volatility131.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.